$GH

Cathie Wood’s ARK buys Guardant Health stock, sells Iridium

ARK ETFs bought 9,070 shares of Guardant Health (GH) for $1.52M and 9,037 shares of AeroVironment (AVAV) for $1.39M. They sold 25,964 shares of Iridium (IRDM) for $1.2M, 313 shares of Teledyne (TDY) for $186,895, and 294 shares of Alphabet (GOOGL) for $102,720. These moves align with ARK's strategy of portfolio recalibration.

Original reporting
Published Sep 16, 2026, 12:09 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 2:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$GH
Bullish
medium confidence
Mentioned
$GH · $AVAV · $IRDM · $TDY · $GOOGL
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$GHBullishLow
01

Why it matters

The disclosed trades provide fresh data on ARK's positioning, offering traders clues on short‑term sentiment for the listed stocks.

02

Market read

Fund activity updates are modestly relevant for traders focusing on the affected stocks, but overall market impact is limited.

03

What to watch

Potential upcoming earnings releases for Guardant Health and AeroVironment could amplify the impact of these trades.

Relevance 4/10Novelty 3/10Timing: pre‑market today

Background

ARK Investment Management regularly publishes daily trade disclosures, which traders monitor for short‑term signals.

Company-level read

Ticker impact

$GHBullishMedium confidence
Context

ARK's ARKG ETF bought 9,070 shares of Guardant Health, adding $1.52M to its position.

Expected impact

Modest upside as fund accumulation signals confidence.

Evidence & confidence

ARK's purchase is sizable for a micro‑cap but still modest relative to market float.

$AVAVBullishMedium confidence
Context

ARK's ARKX ETF purchased 9,037 shares of AeroVironment, worth $1.39M.

Expected impact

Small upward move expected.

Evidence & confidence

Fund buying indicates continued interest, though volume is limited.

$IRDMBearishMedium confidence
Context

ARK's ARKX ETF sold 25,964 shares of Iridium Communications, valued at $1.20M.

Expected impact

Slight dip as the fund reduces exposure.

Evidence & confidence

Selling by a high‑profile fund can trigger sell‑offs in the short term.

$TDYNeutralLow confidence
Context

ARK's ARKQ ETF offloaded 313 shares of Teledyne Technologies, worth $186,895.

Expected impact

No material price change expected.

Evidence & confidence

Trade size is tiny relative to daily volume.

$GOOGLNeutralLow confidence
Context

ARK sold 294 shares of Alphabet across ARKK and ARKW ETFs, totaling $102,720.

Expected impact

No significant price movement anticipated.

Evidence & confidence

Trade is very small for a mega‑cap.

Market effects

Shows ARK's continued tilt toward innovation and satellite/AI‑related stocks.

U.S. equity market, primarily tech and communications sectors.

Limited to investors tracking ARK's portfolio allocations.

Counterpoint

ARK's modest trades may be noise; price moves likely driven by broader market factors.

Key entities

  • Cathie Wood

    Founder of ARK Invest, whose fund actions influence market perception.

  • ARK Investment Management

    Active manager of multiple thematic ETFs.

Related articles

$RKLBMedAI 8/10

Rocket Lab's Revenue Could Top $1.5 Billion in 2027 Without Iridium, Investor Calls Stock a Speculative Buy — BigGo Finance

Rocket Lab (RKLB) reported Q2 2026 revenue of $234M, up 62% YoY, with space systems revenue at $189.5M. The company's backlog reached $2.36B, with $1.1B expected within 12 months. Analysts project 2026 revenue of ~$970M, potentially topping $1.5B in 2027 without Iridium. Rocket Lab plans to acquire Iridium for $8B, expected to close in mid-2027. Shares have a Strong Buy consensus with an avg. target of $110.13.

$GOOGLMedAI 8/10

A judge ruled Google broke antitrust law, then let it keep its entire ad-tech business

A judge ruled Google violated antitrust law but allowed it to keep its ad-tech business. The order requires Google to make its systems interoperable with rivals, share more auction data, and appoint a compliance monitor. The Justice Department sought a breakup, but the judge deemed it unnecessary. Google's ad-tech business generated $30B in 2023, though revenue has declined for 16 quarters.

$GOOGLMed

Alphabet (GOOGL) Starts Las Vegas Robotaxis And Targets Tokyo By 2027

Alphabet's (GOOGL) Waymo launched a commercial robotaxi service in Las Vegas and plans to expand to Tokyo by 2027. The move aligns with Alphabet's strategy to diversify beyond advertising, but investors weigh the potential for long-term gains against ongoing losses. Waymo's success could impact Alphabet's margins and growth prospects.

$RKLBMed

Rocket Lab Jumps 6% as FCC Clears First Hurdle on Iridium Deal; Iridium Communications Barely Budges

Rocket Lab (RKLB) shares rose 6% after the FCC accepted its license-transfer applications for acquiring Iridium Communications (IRDM), opening a public-comment period. Iridium's stock barely moved, up 0.2%. The ARK Space Exploration & Innovation ETF (ARKX) gained 2%, outpacing the S&P 500 ETF (SPY). SpaceX has asked the FCC to examine Iridium's conduct toward rival satellite operators.